Pathology oncology research : POR

Keyphrases

Publications

volume 30, 2024

Emese Csiki, Mihály Simon, Judit Papp, Márton Barabás, Johanna Mikáczó, Kristóf Gál, David Sipos, Árpád Kovács
Stereotactic body radiotherapy in lung cancer: a contemporary review. Pathology oncology research : POR 30 (2024)
William John Hatchett, Marta Brunetti, Kristin Andersen, Maren Randi Tandsæther, Ingvild Lobmaier, Marius Lund-Iversen, Thomas Lien-Dahl, Francesca Micci, Ioannis Panagopoulos
Genetic characterization of intramuscular myxomas. Pathology oncology research : POR 30 (2024)
Jie Dai, Yong Jiang, Haoyue Hu, Shuang Zhang, Yue Chen
Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment. Pathology oncology research : POR 30 (2024)
Andrea Molnár, Erzsébet Pálfi, Barbara Belák, Célia Blasszauer, Dániel Reibl, József Lövey
Positive correlation between persistence of medical nutrition therapy and overall survival in patients with head and neck cancer. Pathology oncology research : POR 30 (2024)
William John Hatchett, Marta Brunetti, Kristin Andersen, Maren Randi Tandsæther, Ingvild Lobmaier, Marius Lund-Iversen, Thomas Lien-Dahl, Francesca Micci, Ioannis Panagopoulos
Genetic characterization of intramuscular myxomas. Pathology oncology research : POR 30 (2024)
Miklós Bély, Ágnes Apáthy
Crystal induced arthropathies-a comparative study of 40 patients with apatite rheumatism, chondrocalcinosis and primary synovial chondromatosis. Pathology oncology research : POR 30 (2024)
Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Judit Demeter
Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary. Pathology oncology research : POR 30 (2024)
József Tímár, Andrea Ladányi, Anna Sebestyén, László Kopper
Editorial: Pathology and Oncology Research: addressing publication ethics issues. Pathology oncology research : POR 30 (2024)
Anna Jakab, Árpád V Patai, Mónika Darvas, Karolina Tormássi-Bély, Tamás Micsik
Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer. Pathology oncology research : POR 30 (2024)
Anna Jakab, Árpád V Patai, Mónika Darvas, Karolina Tormássi-Bély, Tamás Micsik
Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer. Pathology oncology research : POR 30 (2024)
Lina Hu, James Tiesinga
Case report: Primary vulvar adenocarcinoma of mammary gland type-its genetic characteristics by focused next-generation sequencing. Pathology oncology research : POR 30 (2024)
Jörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, Andreas Bräuninger, Kristin Hartung, Uwe Gerstenmaier, Ralf Marienfeld, Axel Hillmer, Nadine Bohn, Christina Lehning, Ferdinand Ferch, Peter Wild, Stefan Gattenlöhner, Peter Möller, Frederick Klauschen, Andreas Jung
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting. Pathology oncology research : POR 30 (2024)
Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Judit Demeter
Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary. Pathology oncology research : POR 30 (2024)
Dániel Sztankovics, Dorottya Moldvai, Gábor Petővári, Titanilla Dankó, Fatime Szalai, Risa Miyaura, Viktória Varga, Noémi Nagy, Gergő Papp, Judit Pápay, Ildikó Krencz, Anna Sebestyén
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies. Pathology oncology research : POR 30 (2024)
Andrea Molnár, Erzsébet Pálfi, Barbara Belák, Célia Blasszauer, Dániel Reibl, József Lövey
Positive correlation between persistence of medical nutrition therapy and overall survival in patients with head and neck cancer. Pathology oncology research : POR 30 (2024)
Jiaxin Wu, Yuanying Wang, Yi Cheng, Li Cheng, Lushun Zhang
Comprehensive landscape and future perspectives of non-coding RNAs in esophageal squamous cell carcinoma, a bibliometric analysis from 2008 to 2023. Pathology oncology research : POR 30 (2024)
Jiaxin Wu, Yuanying Wang, Yi Cheng, Li Cheng, Lushun Zhang
Comprehensive landscape and future perspectives of non-coding RNAs in esophageal squamous cell carcinoma, a bibliometric analysis from 2008 to 2023. Pathology oncology research : POR 30 (2024)
Árpád Kovács, Krisztina Trási, Márton Barabás, Kristóf Gál, Emese Csiki, Dávid Sipos, Judit Papp, Mihály Simon
LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival data analysis. Pathology oncology research : POR 30 (2024)
Emese Csiki, Mihály Simon, Judit Papp, Márton Barabás, Johanna Mikáczó, Kristóf Gál, David Sipos, Árpád Kovács
Stereotactic body radiotherapy in lung cancer: a contemporary review. Pathology oncology research : POR 30 (2024)
Shigeru Sakurai, Yasutaka Ishida, Tomoaki Shintani, Sachiko Yamasaki, Kensaku Matsui, Tomoaki Hamana, Tadayoshi Nobumoto, Souichi Yanamoto, Yasutaka Hayashido
Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study. Pathology oncology research : POR 30 (2024)
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai
Targeted therapeutic options in early and metastatic NSCLC-overview. Pathology oncology research : POR 30 (2024)
null null
Retraction: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma. Pathology oncology research : POR 30 (2024)
Jörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, Andreas Bräuninger, Kristin Hartung, Uwe Gerstenmaier, Ralf Marienfeld, Axel Hillmer, Nadine Bohn, Christina Lehning, Ferdinand Ferch, Peter Wild, Stefan Gattenlöhner, Peter Möller, Frederick Klauschen, Andreas Jung
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting. Pathology oncology research : POR 30 (2024)
Jörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, Andreas Bräuninger, Kristin Hartung, Uwe Gerstenmaier, Ralf Marienfeld, Axel Hillmer, Nadine Bohn, Christina Lehning, Ferdinand Ferch, Peter Wild, Stefan Gattenlöhner, Peter Möller, Frederick Klauschen, Andreas Jung
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting. Pathology oncology research : POR 30 (2024)
Yuqing Liu, Zhenwei Chen, Lu Wang, Baizhou Li
Intestinal Langerhans cell histiocytosis presenting with symptoms similar to inflammatory bowel disease: a case report. Pathology oncology research : POR 30 (2024)
Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Judit Demeter
Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary. Pathology oncology research : POR 30 (2024)
Yuqing Liu, Zhenwei Chen, Lu Wang, Baizhou Li
Intestinal Langerhans cell histiocytosis presenting with symptoms similar to inflammatory bowel disease: a case report. Pathology oncology research : POR 30 (2024)
Jörg Kumbrink, Melanie-Christin Demes, Jan Jeroch, Andreas Bräuninger, Kristin Hartung, Uwe Gerstenmaier, Ralf Marienfeld, Axel Hillmer, Nadine Bohn, Christina Lehning, Ferdinand Ferch, Peter Wild, Stefan Gattenlöhner, Peter Möller, Frederick Klauschen, Andreas Jung
Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting. Pathology oncology research : POR 30 (2024)
Lina Hu, James Tiesinga
Case report: Primary vulvar adenocarcinoma of mammary gland type-its genetic characteristics by focused next-generation sequencing. Pathology oncology research : POR 30 (2024)
null null
Retraction: MiR-184 retarded the proliferation, invasiveness and migration of glioblastoma cells by repressing stanniocalcin-2. Pathology oncology research : POR 30 (2024)
Dániel Sztankovics, Dorottya Moldvai, Gábor Petővári, Titanilla Dankó, Fatime Szalai, Risa Miyaura, Viktória Varga, Noémi Nagy, Gergő Papp, Judit Pápay, Ildikó Krencz, Anna Sebestyén
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies. Pathology oncology research : POR 30 (2024)
Dániel Sztankovics, Dorottya Moldvai, Gábor Petővári, Titanilla Dankó, Fatime Szalai, Risa Miyaura, Viktória Varga, Noémi Nagy, Gergő Papp, Judit Pápay, Ildikó Krencz, Anna Sebestyén
mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies. Pathology oncology research : POR 30 (2024)
Miklós Bély, Ágnes Apáthy
Crystal induced arthropathies-a comparative study of 40 patients with apatite rheumatism, chondrocalcinosis and primary synovial chondromatosis. Pathology oncology research : POR 30 (2024)
Yuqing Liu, Zhenwei Chen, Lu Wang, Baizhou Li
Intestinal Langerhans cell histiocytosis presenting with symptoms similar to inflammatory bowel disease: a case report. Pathology oncology research : POR 30 (2024)
Jiaxin Wu, Yuanying Wang, Yi Cheng, Li Cheng, Lushun Zhang
Comprehensive landscape and future perspectives of non-coding RNAs in esophageal squamous cell carcinoma, a bibliometric analysis from 2008 to 2023. Pathology oncology research : POR 30 (2024)
Monika Fekete, David Major, Agnes Feher, Vince Fazekas-Pongor, Andrea Lehoczki
Geroscience and pathology: a new frontier in understanding age-related diseases. Pathology oncology research : POR 30 (2024)
Peter Batar, Hussain Alizadeh, Gyorgy Rokszin, Zsolt Abonyi-Toth, Judit Demeter
Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary. Pathology oncology research : POR 30 (2024)
Monika Fekete, David Major, Agnes Feher, Vince Fazekas-Pongor, Andrea Lehoczki
Geroscience and pathology: a new frontier in understanding age-related diseases. Pathology oncology research : POR 30 (2024)
Árpád Kovács, Krisztina Trási, Márton Barabás, Kristóf Gál, Emese Csiki, Dávid Sipos, Judit Papp, Mihály Simon
LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival data analysis. Pathology oncology research : POR 30 (2024)
József Tímár, Andrea Ladányi, Anna Sebestyén, László Kopper
Editorial: Pathology and Oncology Research: addressing publication ethics issues. Pathology oncology research : POR 30 (2024)
Jie Dai, Yong Jiang, Haoyue Hu, Shuang Zhang, Yue Chen
Extracellular vesicles as modulators of glioblastoma progression and tumor microenvironment. Pathology oncology research : POR 30 (2024)
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai
Targeted therapeutic options in early and metastatic NSCLC-overview. Pathology oncology research : POR 30 (2024)
Shigeru Sakurai, Yasutaka Ishida, Tomoaki Shintani, Sachiko Yamasaki, Kensaku Matsui, Tomoaki Hamana, Tadayoshi Nobumoto, Souichi Yanamoto, Yasutaka Hayashido
Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study. Pathology oncology research : POR 30 (2024)
Anna Jakab, Árpád V Patai, Mónika Darvas, Karolina Tormássi-Bély, Tamás Micsik
Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer. Pathology oncology research : POR 30 (2024)
Anna Jakab, Árpád V Patai, Mónika Darvas, Karolina Tormássi-Bély, Tamás Micsik
Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer. Pathology oncology research : POR 30 (2024)
Maja L Nádorvári, Gábor Lotz, Janina Kulka, András Kiss, József Tímár
Microsatellite instability and mismatch repair protein deficiency: equal predictive markers? Pathology oncology research : POR 30 (2024)
Yuqing Liu, Zhenwei Chen, Lu Wang, Baizhou Li
Intestinal Langerhans cell histiocytosis presenting with symptoms similar to inflammatory bowel disease: a case report. Pathology oncology research : POR 30 (2024)
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai
Targeted therapeutic options in early and metastatic NSCLC-overview. Pathology oncology research : POR 30 (2024)
Gabriella Gálffy, Éva Morócz, Réka Korompay, Réka Hécz, Réka Bujdosó, Rita Puskás, Tímea Lovas, Eszter Gáspár, Kamel Yahya, Péter Király, Zoltán Lohinai
Targeted therapeutic options in early and metastatic NSCLC-overview. Pathology oncology research : POR 30 (2024)
Shigeru Sakurai, Yasutaka Ishida, Tomoaki Shintani, Sachiko Yamasaki, Kensaku Matsui, Tomoaki Hamana, Tadayoshi Nobumoto, Souichi Yanamoto, Yasutaka Hayashido
Clinical significance of integrin αV and β superfamily members and focal adhesion kinase activity in oral squamous cell carcinoma: a retrospective observational study. Pathology oncology research : POR 30 (2024)